WilmerHale Advises Thermo Fisher on $1.2B USD and €1.25B EUR Notes Offerings
- 12.2.2022
WilmerHale represented Thermo Fisher Scientific Inc. in connection with its public offering of €500.0 million aggregate principal amount of 3.200% Senior Notes due 2026 and €750.0 million aggregate principal amount of 3.650% Senior Notes due 2034 and its public offering of $600.0 million aggregate principal amount of 4.800% Senior Notes due 2027 and $600.0 million aggregate principal amount of 4.950% Senior Notes due 2032. Both offerings were priced on November 14, 2022 and closed on November 21, 2022. Citigroup Global Markets Limited, Deutsche Bank AG, London Branch and Merrill Lynch International acted as representatives of the underwriters for the Eurobond offering and BofA Securities, Inc., Citigroup Global Markets Inc. and Deutsche Bank Securities Inc. acted as representatives of the underwriters for the US dollar-denominated offering.
The WilmerHale legal team advising Thermo Fisher Scientific Inc on both offerings consisted of Erika Robinson, Justin Ochs, Molly Fox, Timothy Silva, Julie Hogan-Rodgers, Andrew Langworthy, Ryan S. Brewer, Ryan Lombardo, Ben Lobley and Mazen Osman.
